Scientists at the University of Bonn in Germany and The Hebrew University of Jerusalem in Israel, found that old mice were able to regress to the state of two-month-old mice with a prolonged treatment with a cannabis active ingredient.
Cognitive ability decreases with increasing age. Although this process is normal, it can also promote dementia.
Researchers have long been looking for ways to slow down or even reverse this process. Scientists have now achieved this in mice.
The researchers administered a small quantity of THC, the active ingredient in cannabis, to mice aged two, twelve and 18 months over a period of four weeks.
Afterwards, they tested learning capacity and memory performance in the animals - including orientation skills and the recognition of other mice.
Mice who were only given a placebo displayed natural age-dependent learning and memory losses. In contrast, the cognitive functions of the animals treated with cannabis were just as good as the two-month-old control animals.
The researchers had earlier discovered that the brain ages much faster when mice do not possess any functional receptors for THC.
These cannabinoid 1 (CB1) receptors are proteins to which the substances dock and thus trigger a signal chain. CB1 is also the reason for the intoxicating effect of THC in cannabis products, such as hashish or marijuana, which accumulate at the receptor.
THC imitates the effect of cannabinoids produced naturally in the body, which fulfil important functions in the brain.
"When the activity of the cannabinoid system declines, we find rapid ageing in the brain," he said.
To discover precisely what effect the THC treatment has in old mice, the researchers examined the brain tissue and gene activity of the treated mice.
They found that the molecular signature no longer correspondeds to that of old animals, but was instead very similar to that of young animals.
The number of links between the nerve cells in the brain also increased again, which is an important prerequisite for learning ability.
The results are now presented in the journal Nature Medicine.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
